| UniProt ID | CMGA_HUMAN | |
|---|---|---|
| UniProt AC | P10645 | |
| Protein Name | Chromogranin-A | |
| Gene Name | CHGA | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 457 | |
| Subcellular Localization | Cytoplasmic vesicle, secretory vesicle lumen. Cytoplasmic vesicle, secretory vesicle membrane. Secreted. Associated with the secretory granule membrane through direct interaction to SCG3 that in turn binds to cholesterol-enriched lipid rafts in intra | |
| Protein Description | Pancreastatin: Strongly inhibits glucose induced insulin release from the pancreas.; Catestatin: Inhibits catecholamine release from chromaffin cells and noradrenergic neurons by acting as a non-competitive nicotinic cholinergic antagonist. [PubMed: 15326220 Displays antibacterial activity against Gram-positive bacteria S.aureus and M.luteus, and Gram-negative bacteria E.coli and P.aeruginosa] | |
| Protein Sequence | MRSAAVLALLLCAGQVTALPVNSPMNKGDTEVMKCIVEVISDTLSKPSPMPVSQECFETLRGDERILSILRHQNLLKELQDLALQGAKERAHQQKKHSGFEDELSEVLENQSSQAELKEAVEEPSSKDVMEKREDSKEAEKSGEATDGARPQALPEPMQESKAEGNNQAPGEEEEEEEEATNTHPPASLPSQKYPGPQAEGDSEGLSQGLVDREKGLSAEPGWQAKREEEEEEEEEAEAGEEAVPEEEGPTVVLNPHPSLGYKEIRKGESRSEALAVDGAGKPGAEEAQDPEGKGEQEHSQQKEEEEEMAVVPQGLFRGGKSGELEQEEERLSKEWEDSKRWSKMDQLAKELTAEKRLEGQEEEEDNRDSSMKLSFRARAYGFRGPGPQLRRGWRPSSREDSLEAGLPLQVRGYPEEKKEEEGSANRRPEDQELESLSAIEAELEKVAHQLQALRRG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 48 | O-linked_Glycosylation | SDTLSKPSPMPVSQE HHHCCCCCCCCCCHH | 37.25 | OGP | |
| 53 | Phosphorylation | KPSPMPVSQECFETL CCCCCCCCHHHHHHH | 17.87 | 26657352 | |
| 59 | Phosphorylation | VSQECFETLRGDERI CCHHHHHHHCCCHHH | 11.08 | 29691806 | |
| 88 | Ubiquitination | DLALQGAKERAHQQK HHHHHHHHHHHHHHH | 55.33 | - | |
| 98 | Phosphorylation | AHQQKKHSGFEDELS HHHHHCCCCHHHHHH | 54.80 | 26657352 | |
| 105 | Phosphorylation | SGFEDELSEVLENQS CCHHHHHHHHHHCCC | 24.50 | 26657352 | |
| 112 | Phosphorylation | SEVLENQSSQAELKE HHHHHCCCCHHHHHH | 35.68 | 26657352 | |
| 113 | Phosphorylation | EVLENQSSQAELKEA HHHHCCCCHHHHHHH | 24.52 | 26657352 | |
| 125 | Phosphorylation | KEAVEEPSSKDVMEK HHHHHCCCHHHHHHH | 53.98 | 29691806 | |
| 126 | Phosphorylation | EAVEEPSSKDVMEKR HHHHCCCHHHHHHHH | 43.52 | 26657352 | |
| 136 | Phosphorylation | VMEKREDSKEAEKSG HHHHHHHHHHHHHHC | 27.87 | 26657352 | |
| 142 | Phosphorylation | DSKEAEKSGEATDGA HHHHHHHHCCCCCCC | 33.11 | 26657352 | |
| 146 | Phosphorylation | AEKSGEATDGARPQA HHHHCCCCCCCCCCC | 30.57 | 26657352 | |
| 161 | Phosphorylation | LPEPMQESKAEGNNQ CCCCHHHHHCCCCCC | 21.92 | 27732954 | |
| 181 | O-linked_Glycosylation | EEEEEEATNTHPPAS HHHHHHHHCCCCCCC | 43.88 | 9852066 | |
| 181 | Phosphorylation | EEEEEEATNTHPPAS HHHHHHHHCCCCCCC | 43.88 | 23312004 | |
| 181 | O-linked_Glycosylation | EEEEEEATNTHPPAS HHHHHHHHCCCCCCC | 43.88 | 9852066 | |
| 183 | Phosphorylation | EEEEATNTHPPASLP HHHHHHCCCCCCCCC | 31.25 | 23312004 | |
| 183 | O-linked_Glycosylation | EEEEATNTHPPASLP HHHHHHCCCCCCCCC | 31.25 | 9852066 | |
| 183 | O-linked_Glycosylation | EEEEATNTHPPASLP HHHHHHCCCCCCCCC | 31.25 | 9852066 | |
| 188 | Phosphorylation | TNTHPPASLPSQKYP HCCCCCCCCCCCCCC | 46.73 | 26657352 | |
| 191 | O-linked_Glycosylation | HPPASLPSQKYPGPQ CCCCCCCCCCCCCCC | 44.60 | OGP | |
| 191 | Phosphorylation | HPPASLPSQKYPGPQ CCCCCCCCCCCCCCC | 44.60 | 23312004 | |
| 194 | Phosphorylation | ASLPSQKYPGPQAEG CCCCCCCCCCCCCCC | 13.04 | 8910482 | |
| 203 | Phosphorylation | GPQAEGDSEGLSQGL CCCCCCCCCCHHHCC | 44.41 | 26657352 | |
| 207 | Phosphorylation | EGDSEGLSQGLVDRE CCCCCCHHHCCCCHH | 32.81 | 26657352 | |
| 207 | O-linked_Glycosylation | EGDSEGLSQGLVDRE CCCCCCHHHCCCCHH | 32.81 | - | |
| 207 | O-linked_Glycosylation | EGDSEGLSQGLVDRE CCCCCCHHHCCCCHH | 32.81 | 9115255 | |
| 218 | Phosphorylation | VDREKGLSAEPGWQA CCHHHCCCCCCCHHH | 38.97 | 26657352 | |
| 251 | O-linked_Glycosylation | VPEEEGPTVVLNPHP CCCCCCCEEEECCCC | 33.82 | 9115255 | |
| 251 | O-linked_Glycosylation | VPEEEGPTVVLNPHP CCCCCCCEEEECCCC | 33.82 | 9115255 | |
| 270 | Phosphorylation | KEIRKGESRSEALAV CHHHCCCCHHHHHCC | 50.18 | 22817900 | |
| 272 | Phosphorylation | IRKGESRSEALAVDG HHCCCCHHHHHCCCC | 36.18 | 23312004 | |
| 300 | Phosphorylation | GKGEQEHSQQKEEEE CCCHHHHHHHHHHHH | 33.29 | 26657352 | |
| 319 | Amidation | VPQGLFRGGKSGELE CCCCHHCCCCCCCHH | 40.31 | 2830133 | |
| 319 | Glycine amide | VPQGLFRGGKSGELE CCCCHHCCCCCCCHH | 40.31 | - | |
| 322 | Phosphorylation | GLFRGGKSGELEQEE CHHCCCCCCCHHHHH | 40.55 | 14997482 | |
| 333 | Phosphorylation | EQEEERLSKEWEDSK HHHHHHHHHHHHHHH | 34.45 | 14997482 | |
| 339 | Phosphorylation | LSKEWEDSKRWSKMD HHHHHHHHHHHHHHH | 16.77 | 27732954 | |
| 370 | Phosphorylation | EEEDNRDSSMKLSFR CCCCCCCCHHHHHHH | 29.15 | 24719451 | |
| 371 | Phosphorylation | EEDNRDSSMKLSFRA CCCCCCCHHHHHHHH | 24.99 | 23312004 | |
| 372 | Oxidation | EDNRDSSMKLSFRAR CCCCCCHHHHHHHHH | 6.15 | 17991725 | |
| 372 | Methionine sulfoxide | EDNRDSSMKLSFRAR CCCCCCHHHHHHHHH | 6.15 | - | |
| 373 | Ubiquitination | DNRDSSMKLSFRARA CCCCCHHHHHHHHHH | 42.82 | - | |
| 375 | Phosphorylation | RDSSMKLSFRARAYG CCCHHHHHHHHHHHC | 13.73 | 25554490 | |
| 381 | Phosphorylation | LSFRARAYGFRGPGP HHHHHHHHCCCCCCH | 15.96 | 24043423 | |
| 397 | Phosphorylation | LRRGWRPSSREDSLE CCCCCCCCCHHHHHH | 33.19 | 26657352 | |
| 398 | Phosphorylation | RRGWRPSSREDSLEA CCCCCCCCHHHHHHC | 42.23 | 26657352 | |
| 402 | Phosphorylation | RPSSREDSLEAGLPL CCCCHHHHHHCCCCC | 24.29 | 21082442 | |
| 424 | Phosphorylation | EKKEEEGSANRRPED HHCCCCCCCCCCHHH | 26.17 | - | |
| 432 | Pyrrolidone_carboxylic_acid | ANRRPEDQELESLSA CCCCHHHHHHHHHHH | 56.35 | - | |
| 436 | Phosphorylation | PEDQELESLSAIEAE HHHHHHHHHHHHHHH | 40.00 | 26657352 | |
| 438 | Phosphorylation | DQELESLSAIEAELE HHHHHHHHHHHHHHH | 36.16 | 26657352 | |
| 456 | Amidation | HQLQALRRG------ HHHHHHHCC------ | 56.90 | 12442257 | |
| 456 | Arginine amide | HQLQALRRG------ HHHHHHHCC------ | 56.90 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CMGA_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CMGA_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CMGA_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SAPC2_HUMAN | SAPCD2 | physical | 28514442 | |
| SGF29_HUMAN | CCDC101 | physical | 28514442 | |
| DENR_HUMAN | DENR | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00034 | Carcinoid | |||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Amidation | |
| Reference | PubMed |
| "Isolation of human pancreastatin fragment containing the activesequence from a glucagonoma."; Sekiya K., Ghatei M.A., Minamino N., Bretherton-Watt D., Matsuo H.,Bloom S.R.; FEBS Lett. 228:153-156(1988). Cited for: PROTEIN SEQUENCE OF 291-319. | |
| O-linked Glycosylation | |
| Reference | PubMed |
| "Phosphorylation and O-glycosylation sites of human chromogranin A(CGA79-439) from urine of patients with carcinoid tumors."; Gadroy P., Stridsberg M., Capon C., Michalski J.-C., Strub J.-M.,van Dorsselaer A., Aunis D., Metz-Boutigue M.-H.; J. Biol. Chem. 273:34087-34097(1998). Cited for: GLYCOSYLATION AT THR-181; THR-183 AND THR-251, AND PHOSPHORYLATION ATSER-218; SER-270 AND SER-333. | |
| Phosphorylation | |
| Reference | PubMed |
| "Phosphoproteomic analysis of the human pituitary."; Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.; Pituitary 9:109-120(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112; SER-113; SER-136;SER-142; SER-203; SER-300; SER-322; SER-333 AND SER-402, AND MASSSPECTROMETRY. | |
| "Identification and characterization of phosphorylated proteins in thehuman pituitary."; Giorgianni F., Beranova-Giorgianni S., Desiderio D.M.; Proteomics 4:587-598(2004). Cited for: PHOSPHORYLATION AT SER-322. | |
| "Phosphorylation and O-glycosylation sites of human chromogranin A(CGA79-439) from urine of patients with carcinoid tumors."; Gadroy P., Stridsberg M., Capon C., Michalski J.-C., Strub J.-M.,van Dorsselaer A., Aunis D., Metz-Boutigue M.-H.; J. Biol. Chem. 273:34087-34097(1998). Cited for: GLYCOSYLATION AT THR-181; THR-183 AND THR-251, AND PHOSPHORYLATION ATSER-218; SER-270 AND SER-333. | |